In what may be the largest award ever against a pharmaceutical company, after more than 12 weeks of trial, it took a Louisiana jury only a few hours to return a verdict in the first federal case involving the development of bladder cancer from side effects of Actos. The jurors found for the plaintiff and awarded $1.5 million in compensatory damages and an additional $9 billion in punitive damages against Takeda Pharmaceuticals and Eli Lilly. The case was based on the allegation that the makers of the diabetes drug Actos withheld information from consumers and the medical community about the risk of users developing bladder cancer. There are still aBout 3,000 other complaints pending involving nearly identical allegations. AboutLawsuits has many more details on the story here.